Saturday 17 October 2026
Export ITOC’s income statement to Excel — free account
iTonic Holdings Ltd.
ITOC Healthcare Medical Devices
iTonic Holdings Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $523,000.00, up 16.7% from fiscal 2024.
3.84
0.17
−4.24%
Follow ITOC
| Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|
Piotroski F-Score |
— | — | 4 | 2 |
Altman Z-Score |
— | — | 1,000.59 | 64.62 |
Altman Z″-Score (non-manufacturers) |
1.88 | (3.48) | 17.02 | 5.57 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | (3.76) | (1.95) | (3.73) |
P/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.00 | 0.00 | 0.00 | 0.66 |
EV/FCF |
0.00 | 0.00 | 0.00 | 0.66 |
Quick Ratio |
0.76 | 0.36 | 12.05 | 6.98 |
Current Ratio |
1.06 | 0.44 | 12.40 | 8.83 |
Net Debt/EBITDA |
(2.63) | 0.76 | 7.80 | 0.54 |
Debt/Assets |
0.00% | 0.00% | 3.69% | 1.57% |
Debt/Equity |
0.00 | 0.00 | 0.04 | 0.02 |
Asset Turnover |
0.00 | 0.42 | 0.11 | 0.07 |
Operating CF/Net income |
(1.38) | 0.26 | 1.17 | 0.63 |
Capex/Depreciation |
— | 0.00 | (0.07) | (0.29) |
| 0.00% | (55.92%) | (20.35%) | (71.24%) | |
| 0.00% | (15.98%) | (15.84%) | (64.45%) | |
ROIC |
3.55% | (243.26%) | (176.42%) | (60.67%) |
Return on Tangible Assets |
218.75% | 39.28% | (10.68%) | (139.16%) |
Average Days of Receivables |
240.60 | 119.79 | 270.04 | 212.65 |
Research and Development Expense of Revenue |
10.84% | 13.44% | 20.82% | 87.78% |
Selling, General and Administrative Expense of Revenue |
67.21% | 110.24% | 236.08% | 966.58% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.48 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 563.19% |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
0.06 | 0.05 | 0.04 | 0.03 |
Operating CF per Share |
(0.01) | (0.01) | (0.06) | (0.20) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.01) | (0.01) | (0.06) | (0.20) |
Cash per Share |
0.01 | 0.02 | 0.48 | 0.18 |
Shareholders Equity per Share |
0.05 | 0.03 | 0.49 | 0.51 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.05 | 0.03 | 0.49 | 0.51 |
Free Cash Flow |
(0.12) | (0.06) | (0.78) | (3.24) |
Working Capital |
0.04 | (0.67) | 6.14 | 3.63 |
Capital Expenditures |
— | — | 0.00 | 0.00 |
Net Current Asset Value |
(0.13) | (0.78) | 6.14 | 3.12 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.01 |
| Other line items | ||||
Depreciation/Fixed assets |
— | 0.09 | 0.28 | 0.35 |
Cash ROIC |
(18.49%) | (11.91%) | (6.16%) | (28.90%) |
Accounts Receivable Turnover |
0.00 | 1.92 | 1.67 | 1.64 |
Accounts Payable Turnover |
0.00 | 10.81 | 4.72 | 5.06 |
Inventory Turnover |
0.00 | 1.54 | 0.79 | 2.30 |
Average Days of Payables |
33.62 | 41.64 | 56.66 | 124.78 |
Days of Inventory on Hand |
458.65 | 120.97 | 639.57 | 97.92 |
Average Receivables |
— | 0.33 | 0.27 | 0.32 |
Average Payables |
— | 0.01 | 0.01 | 0.04 |
Average Inventory |
— | 0.10 | 0.08 | 0.08 |
Average Assets |
— | 1.51 | 4.17 | 7.91 |
Average Common Equity |
— | 0.43 | 3.25 | 7.16 |
Columns are period end dates · fundamentals updated 2 Oct 2026